In Two Analyses, MAESTRO-NAFLD-1 Trial Shows Safety of Resmetirom ...Middle East

Medscape - News
In main results from the phase 3 trial, as well as those from an open-label extension, the investigational drug also proved its ability to positively influence several noninvasive efficacy outcomes. Medscape Medical News

Read More Details
Finally We wish PressBee provided you with enough information of ( In Two Analyses, MAESTRO-NAFLD-1 Trial Shows Safety of Resmetirom )

Also on site :